In Vitro Effect of Dovitinib (TKI258), a Multi-Target Angiokinase Inhibitor on Aggressive Meningioma Cells
Sign Up to like & getrecommendations! Published in 2020 at "Cancer Investigation"
DOI: 10.1080/07357907.2020.1773844
Abstract: Abstract Background: Meningiomas represent ∼30% of primary central nervous system (CNS) tumors. Although advances in surgery and radiotherapy have significantly improved survival, there remains an important subset of patients whose tumors have more aggressive behavior… read more here.
Keywords: multi; dovitinib; inhibitor; vitro effect ... See more keywords